|
 |
Asia bullish on biologics manufacturing
 |
|
| The opportunity has the promise of attracting mega investments from the big pharma. Pre-requisite is meeting the biggest challenge for Asian biologics manufacturers X that of harmonizing their infrastructure with European and US FDA requirements
|
|
 |
|
|
| |
| Pentavalent vaccines in India
|
|
| In a move that would change the history of immunization in India, the Indian government has started administering pentavalent vaccine in place of the existing trivalent DPT vaccine in two states |
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| Taking antiviral technology global
|
|
| Malaysia-based BioValence is developing next-generation antiviral technologies and multifunctional drugs that target viruses at multiple points of their life cycle |
|
|
|
|
| More |
